-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Benitec Biopharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to Q3 2025.
- Benitec Biopharma Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 41.5M shares, a 48.9% increase year-over-year.
- Benitec Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 36.2M shares, a 97.2% increase from 2024.
- Benitec Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 18.4M shares, a 1225% increase from 2023.
- Benitec Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.39M shares, a 188% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)